|

Electroporation for Cancer Treatment Real World Registry

RECRUITINGSponsored by Mirai Medical
Actively Recruiting
SponsorMirai Medical
Started2021-06-24
Est. completion2026-12-24
View on ClinicalTrials.gov →

NCT04929912

Summary

This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.

Eligibility

Inclusion Criteria:

* Any patient who has been treated using Calcium Electroporation
* Any patient who has been treated using Electrochemotherapy
* Patients must be mentally capable of understanding the information given
* Patients must give written informed consent.

Exclusion Criteria:

* None

Conditions3

CancerGastrointestinal CancerSkin Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.